SALEKI-GERHARDT AZITA
SEC CIK 1563545 · EDGAR
BoughtSold
Most active insiders at ENTG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LOY BERTRAND | Executive COB, Dir | — | $36.23M |
| 2 | Woodland Daniel D. | SVP, Pres, MS Division | — | $3.98M |
| 3 | Rice Susan G. | SVP, Gbl Human Resources | — | $2.95M |
| 4 | Haris Clinton M. | SVP, Pres, APS Division | — | $2.56M |
| 5 | Colella Joseph | SVP, GC | — | $2.24M |
| 6 | LaGorga Linda | SVP, CFO | — | $1.54M |
| 7 | Blachier Olivier | SVP, Chief Strategy Off | — | $889.8K |
| 8 | LEDERER JAMES P | Dir | — | $698.9K |
| 9 | Clark Rodney | Dir | — | — |
| 10 | Nagesh Sukhi | SVP, CFO | — | — |
| 12 | SALEKI-GERHARDT AZITA | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 12:55 | 2026-05-06 | ENTG | ENTEGRIS INC | SALEKI-GERHARDT AZITA | Dir | A - Grant | $0.00 | +1,412 | 26.4K | +6% | $0 | |
| 2026-03-03 | 2026-02-27 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | F - Tax | $232.08 | -16.3K | 197.8K | -8% | -$3.78M | |
| DM | 2026-02-20 | 2026-02-18 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | A - Grant | $0.00 | +36.8K | 214.1K | +21% | $0 |
| D | 2025-08-14 | 2025-08-12 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | S - Sale+OE | $198.42 | -42.4K | 177.3K | -19% | -$8.41M |
| D | 2025-08-14 | 2025-08-12 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | M - OptEx | $54.86 | +42.4K | 219.7K | +24% | +$2.32M |
| 2025-04-25 | 2025-04-23 | ENTG | ENTEGRIS INC | SALEKI-GERHARDT AZITA | Dir | A - Grant | $0.00 | +2,897 | 25.0K | +13% | $0 | |
| 2025-03-04 | 2025-02-28 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | F - Tax | $205.02 | -17.1K | 177.3K | -9% | -$3.50M | |
| DM | 2025-02-18 | 2025-02-13 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | A - Grant | $0.00 | +38.5K | 232.8K | +20% | $0 |
| 2024-09-30 | 2024-09-24 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | G - Gift | $0.00 | -25.6K | 194.3K | -12% | $0 | |
| 2024-04-25 | 2024-04-24 | ENTG | ENTEGRIS INC | SALEKI-GERHARDT AZITA | Dir | A - Grant | $0.00 | +1,643 | 22.1K | +8% | $0 | |
| 2024-03-01 | 2024-02-28 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | F - Tax | $178.99 | -24.0K | 220.0K | -10% | -$4.29M | |
| D | 2024-02-23 | 2024-02-21 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | S - Sale+OE | $173.71 | -52.9K | 243.9K | -18% | -$9.18M |
| D | 2024-02-23 | 2024-02-21 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | M - OptEx | $58.88 | +52.9K | 296.8K | +22% | +$3.11M |
| DM | 2024-02-20 | 2024-02-15 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | A - Grant | $0.00 | +54.1K | 243.9K | +28% | $0 |
| 2023-04-28 | 2023-04-26 | ENTG | ENTEGRIS INC | SALEKI-GERHARDT AZITA | Dir | A - Grant | $0.00 | +2,849 | 20.4K | +16% | $0 | |
| DM | 2023-03-02 | 2023-03-01 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Ops | S - Sale+OE | $154.48 | -37.0K | 199.8K | -16% | -$5.71M |
| D | 2023-03-02 | 2023-03-01 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Ops | M - OptEx | $51.42 | +27.0K | 226.8K | +14% | +$1.39M |
| D | 2023-03-02 | 2023-02-28 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Ops | F - Tax | $154.28 | -33.4K | 199.8K | -14% | -$5.15M |
| DM | 2023-02-21 | 2023-02-17 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Ops | S - Sale+OE | $149.53 | -25.0K | 233.2K | -10% | -$3.74M |
| D | 2023-02-21 | 2023-02-17 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Ops | M - OptEx | $51.42 | +25.0K | 258.2K | +11% | +$1.29M |
| DM | 2023-02-21 | 2023-02-16 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Ops | A - Grant | $0.00 | +75.3K | 206.0K | +58% | $0 |
| 2022-04-29 | 2022-04-27 | ENTG | ENTEGRIS INC | SALEKI-GERHARDT AZITA | Dir | A - Grant | $0.00 | +1,849 | 17.6K | +12% | $0 | |
| 2022-03-01 | 2022-02-25 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Ops | F - Tax | $149.54 | -22.1K | 157.9K | -12% | -$3.31M | |
| DM | 2022-02-22 | 2022-02-17 | ABBV | AbbVie | SALEKI-GERHARDT AZITA | EVP, Ops | A - Grant | $0.00 | +63.7K | 147.5K | +76% | $0 |
Purchase Sale Sale after option exercise All abbreviations